Literature DB >> 9442172

Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome.

K Sharif1, M Elgendy, H Lashen, M Afnan.   

Abstract

OBJECTIVE: To examine the relative effect of basal follicle stimulating hormone (FSH) concentration and the woman's age on predicting the ovarian response to gonadotrophin stimulation, normal fertilisation rate and pregnancy rate in in vitro fertilisation (IVF) treatment following pituitary desensitisation.
DESIGN: Descriptive cohort study. PARTICIPANTS: Three hundred and forty-four women undergoing their first IVF cycle.
METHODS: Basal (menstrual-day 3) FSH concentration was measured and the woman's age calculated before she underwent pituitary desensitisation followed by gonadotrophin ovarian stimulation and IVF treatment. MAIN OUTCOME MEASURES: Cancellation rate due to poor ovarian response, total dose of gonadotrophin required to achieve follicular maturity, number of oocytes collected, normal fertilisation rate and pregnancy rate were compared between banded values of the variables studied.
RESULTS: Increasing basal FSH concentration was associated significantly with increased cancellation rate, but increasing age was not. Both increasing basal FSH and age were associated significantly with increased total gonadotrophin dose, and reduced number of oocytes collected and pregnancy rate. Analysis of variance showed that the association for basal FSH with the number of oocytes was significant, independent of, and stronger than the effects of age. Logistic regression analysis showed that age, but not basal FSH, was independently associated with pregnancy rate. Neither basal FSH, nor age had significant association with normal fertilisation rate.
CONCLUSION: Basal FSH concentration is a better predictor of cancellation rate and of the number of oocytes collected in IVF treatment than age, but age is a stronger predictor of pregnancy rate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442172     DOI: 10.1111/j.1471-0528.1998.tb09360.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  17 in total

1.  Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.

Authors:  Hiroyuki Honnma; Tsuyoshi Baba; Masahiro Sasaki; Yoshiki Hashiba; Hisanori Oguri; Takanori Fukunaga; Toshiaki Endo; Yoshimasa Asada
Journal:  J Assist Reprod Genet       Date:  2011-11-16       Impact factor: 3.412

2.  IVF performance of women who have fluctuating early follicular FSH levels.

Authors:  A Lass; A Gerrard; N Abusheikha; F Akagbosu; P Brinsden
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

3.  The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination.

Authors:  Ernest Hung Yu Ng; William Shu Biu Yeung; Pak Chung Ho
Journal:  J Assist Reprod Genet       Date:  2005-10       Impact factor: 3.412

4.  A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.

Authors:  Seang Lin Tan; Timothy J Child; Anthony P Cheung; Margo R Fluker; Albert Yuzpe; Robert Casper; Peter Leung; Kenneth Cadesky; Victoria J Davis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

5.  Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization.

Authors:  Suresh Kini; H W Raymond Li; Dave Morrell; Sue Pickering; K Joo Thong
Journal:  J Assist Reprod Genet       Date:  2010-05-14       Impact factor: 3.412

6.  Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.

Authors:  F Fábregues; J Balasch; M Creus; F Carmona; B Puerto; L Quintó; R Casamitjana; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

7.  The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Authors:  Qiaohong Lai; Cai Chen; Zhijun Zhang; Shu Zhang; Qilin Yu; Ping Yang; Jun Hu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 8.  A new approach to ovarian reserve testing.

Authors:  Wenjie Sun; Barbara J Stegmann; Melinda Henne; William H Catherino; James H Segars
Journal:  Fertil Steril       Date:  2008-04-22       Impact factor: 7.329

9.  Insulin-like growth factor-1 and soluble FMS-like tyrosine kinase-1 prospectively predict cancelled IVF cycles.

Authors:  Dimitrios Nasioudis; Evelyn Minis; Mohamad Irani; Fabiana Kreines; Steven S Witkin; Steven D Spandorfer
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

Review 10.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.